News
Wegovy News Pushes Novo Nordisk Stock
Digest more
Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...
Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...
Novo Nordisk stock gains as FDA expands Wegovy use, while Ozempic price cut aims to boost access and defend market share.
Novo Nordisks stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, ...
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback